We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$217M
AUM Growth
-$7.82M
Cap. Flow
+$2.35M
Cap. Flow %
1.08%
Top 10 Hldgs %
37.08%
Holding
944
New
14
Increased
196
Reduced
207
Closed
16

Top Buys

Rank Stock Value
1
DOV icon
Dover
DOV
+$3.14M
2
ENPH icon
Enphase Energy
ENPH
+$1.55M
3
GTLS
Chart Industries
GTLS
+$1.36M
4
ON icon
ON Semiconductor
ON
+$1.32M
5
NEE icon
NextEra Energy
NEE
+$1.02M

Sector Composition

Rank Sector Weight
1 Technology 41.16%
2 Healthcare 11.03%
3 Consumer Staples 7.01%
4 Financials 6.41%
5 Industrials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INKT icon
851
MiNK Therapeutics
INKT
$56M
0
IR icon
852
Ingersoll Rand
IR
$33.2B
-40
Closed -$3K
KR icon
853
Kroger
KR
$34.5B
-142
Closed -$7K
SKYY icon
854
First Trust Cloud Computing ETF
SKYY
$2.71B
-15
Closed -$1K
EXPR
855
DELISTED
Express, Inc.
EXPR
0
BKI
856
DELISTED
Black Knight, Inc. Common Stock
BKI
-420
Closed -$25K
MTEM
857
DELISTED
Molecular Templates, Inc.
MTEM
-1
Closed
PTR
858
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$0 ﹤0.01%
7
SIVB
859
DELISTED
SVB Financial Group
SIVB
$0 ﹤0.01%
5

Similar funds

Front Row Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Front Row Advisors held 944 positions worth $217M, down 3.5% from $225M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.2%. Front Row Advisors opened 14 new positions and exited 16, leaving the 944-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q3 2023 buy was Enphase Energy: 10,850 shares worth $1.3M.
  • Front Row Advisors added most to Dover in Q3 2023, an estimated $3.14M increase.
  • Front Row Advisors's biggest Q3 2023 reduction was Idexx Laboratories, cutting an estimated $1.71M.
  • Front Row Advisors fully exited Fortune Brands Innovations in Q3 2023, selling an estimated $83K.
  • Front Row Advisors's ten largest holdings make up 37% of its $217M portfolio in Q3 2023.
  • Front Row Advisors opened 14 new positions and closed 16 in Q3 2023.
  • Front Row Advisors's portfolio value fell 3.5% quarter-over-quarter to $217M.

Based on Front Row Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.